
Over the last 7 days, the Medical Equipment industry has dropped 3.7%, driven by declines in Shanghai MicroPort MedBot (Group) and Shenzhen Edge Medical of 6.3% and 8.9%, respectively. On the other hand Hangzhou Diagens Biotechnology is actually up 5.4%. Overall the industry is down 10% in 12 months. Looking forward, earnings are forecast to grow by 45% annually.
Has the Hong Kong Medical Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 15 Jun 2026 | HK$218.7b | HK$67.8b | HK$4.9b | 16x | 44.6x | 3.2x |
| Wed, 13 May 2026 | HK$247.6b | HK$66.3b | HK$2.5b | 16x | 98.4x | 3.7x |
| Fri, 10 Apr 2026 | HK$245.7b | HK$66.0b | HK$2.5b | 17x | 98.7x | 3.7x |
| Sun, 08 Mar 2026 | HK$231.2b | HK$63.8b | HK$2.4b | 16.6x | 97.4x | 3.6x |
| Tue, 03 Feb 2026 | HK$236.4b | HK$63.5b | HK$2.3b | 18.7x | 101.2x | 3.7x |
| Thu, 01 Jan 2026 | HK$200.0b | HK$62.6b | HK$2.5b | 19.5x | 79.9x | 3.2x |
| Sat, 29 Nov 2025 | HK$213.2b | HK$63.3b | HK$3.1b | 19.4x | 68.9x | 3.4x |
| Mon, 27 Oct 2025 | HK$220.8b | HK$62.8b | HK$3.0b | 20.7x | 74.5x | 3.5x |
| Wed, 24 Sep 2025 | HK$222.8b | HK$62.9b | HK$3.0b | 20.8x | 75x | 3.5x |
| Fri, 22 Aug 2025 | HK$232.7b | HK$62.1b | HK$3.4b | 24.8x | 69.4x | 3.7x |
| Sun, 20 Jul 2025 | HK$200.5b | HK$62.0b | HK$3.2b | 19.9x | 62.3x | 3.2x |
| Tue, 17 Jun 2025 | HK$188.1b | HK$62.0b | HK$3.2b | 21.8x | 58.4x | 3x |
| Thu, 15 May 2025 | HK$166.3b | HK$61.5b | HK$3.2b | 21.5x | 52.1x | 2.7x |
| Sat, 12 Apr 2025 | HK$155.5b | HK$60.6b | HK$3.1b | 20.3x | 49.8x | 2.6x |
| Mon, 10 Mar 2025 | HK$167.8b | HK$58.1b | HK$1.2b | 20.9x | 142.1x | 2.9x |
| Wed, 05 Feb 2025 | HK$146.7b | HK$58.2b | HK$1.2b | 17.4x | 121.8x | 2.5x |
| Fri, 03 Jan 2025 | HK$133.2b | HK$57.8b | HK$1.2b | 16.6x | 113.1x | 2.3x |
| Sun, 01 Dec 2024 | HK$133.4b | HK$58.2b | HK$1.2b | 15.7x | 110.7x | 2.3x |
| Tue, 29 Oct 2024 | HK$141.0b | HK$58.9b | HK$1.3b | 14.4x | 105x | 2.4x |
| Thu, 26 Sep 2024 | HK$123.9b | HK$59.5b | HK$1.3b | 12.6x | 93.3x | 2.1x |
| Sat, 24 Aug 2024 | HK$114.9b | HK$55.2b | -HK$890,978,743.67 | 12.1x | -129x | 2.1x |
| Mon, 22 Jul 2024 | HK$121.7b | HK$53.9b | -HK$1,099,310,967.09 | 12.4x | -110.7x | 2.3x |
| Wed, 19 Jun 2024 | HK$134.7b | HK$54.0b | -HK$1,095,242,536.34 | 13.1x | -123x | 2.5x |
| Fri, 17 May 2024 | HK$157.9b | HK$54.2b | -HK$1,085,195,593.33 | 15.6x | -145.5x | 2.9x |
| Sun, 14 Apr 2024 | HK$144.2b | HK$54.3b | -HK$1,095,677,485.06 | 13.8x | -131.6x | 2.7x |
| Tue, 12 Mar 2024 | HK$154.5b | HK$52.8b | -HK$1,041,398,656.74 | 11.6x | -148.4x | 2.9x |
| Thu, 08 Feb 2024 | HK$150.7b | HK$53.6b | -HK$2,430,271,265.54 | 11.5x | -62x | 2.8x |
| Sat, 06 Jan 2024 | HK$188.9b | HK$53.7b | -HK$2,341,611,546.00 | 14.4x | -80.7x | 3.5x |
| Mon, 04 Dec 2023 | HK$210.4b | HK$53.7b | -HK$2,345,436,488.00 | 16.9x | -89.7x | 3.9x |
| Wed, 01 Nov 2023 | HK$208.6b | HK$52.9b | -HK$2,341,229,365.00 | 18.6x | -89.1x | 3.9x |
| Fri, 29 Sep 2023 | HK$209.6b | HK$52.9b | -HK$2,344,635,616.00 | 16.7x | -89.4x | 4x |
| Sun, 27 Aug 2023 | HK$217.8b | HK$51.7b | -HK$3,491,743,814.00 | 17.6x | -62.4x | 4.2x |
| Tue, 25 Jul 2023 | HK$245.5b | HK$51.1b | -HK$3,936,770,245.00 | 19.3x | -62.4x | 4.8x |
| Thu, 22 Jun 2023 | HK$238.0b | HK$51.2b | -HK$3,944,989,289.00 | 19x | -60.3x | 4.7x |
-60.3x
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 0.19% | |
| Healthcare | -1.00% | |
| Medical Equipment | -3.75% | |
| Medical Supplies | -2.85% | |
| Medical Equipment | -4.02% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2526 Hangzhou Diagens Biotechnology | HK$326.00 | 5.4% +HK$1.5b | n/a | PS152.2x | |
| 2172 MicroPort NeuroScientific | HK$9.59 | 9.0% +HK$453.5m | -26.8% | PE25.8x | |
| 1501 Shanghai INT Medical Instruments | HK$31.84 | 6.2% +HK$389.6m | 29.7% | PE27.9x | |
| 1763 China Isotope & Radiation | HK$18.60 | 6.2% +HK$345.5m | 14.3% | PE15.7x | |
| 3600 Modern Dental Group | HK$5.99 | 3.6% +HK$196.3m | 40.9% | PE9.4x |